B. David Zarley
B. David Zarley is a senior staff writer for Freethink, where he covers health and medicine, including infectious disease, psychedelic research, mental health, and the brain. A graduate of SUNY Fredonia, his work has also appeared in The Atlantic, The Verge, Jezebel, Frieze, Sports Illustrated, VICE, Paste Magazine, and numerous other publications. He lives in Chicago.
Biotechnology can convert enemy viruses into anti-cancer mercenaries.
Most patients with cancer die from metastasis. Stopping it would be a major advance in cancer therapy.
Fluphenazine, once used to treat schizophrenia, is capable of blocking a compound connected to chronic pain.
The spray uses snippets of DNA to gum up virus replication.
The new material may make marine uranium extraction economically feasible.
By creating a type O kidney, they hope to make more organs available for transplant.
The synthetic cartilage was made from cellulose fibers — the stuff found in wood — mixed with a goo called polyvinyl alcohol.
Here's what it means for the field.
Heart muscle is shaped like a spiral, a mystery that has eluded scientists since 1669. New research has recreated the structure.
The world is aging, and with age comes vision decline. New research may have found how to improve eyesight in an accessible way.
NicoBoard is an app that helps parents make sense of a frightening time.
Deep learning AI has accurately created color images from night vision images.
Really simple interventions can greatly reduce indoor temperatures during the summer, particularly in places like the Pacific Northwest.
A successful trial that tested a vaccine against bladder cancer in dogs could help develop a similar one for humans.
The airships have a range of 4,000 nautical miles, can fly for five days, and can cruise as high as 20,000 feet at 80 mph. They take to the skies over Spain in 2026.
The common drug is called gabapentin, which is currently used to control seizures and manage nerve pain.
This isn't America's first rodeo with monkeypox. In 2003, the virus swept across America thanks to a shipment of exotic animals.
The site will be the first working example of a geological disposal facility.
Researchers believe they have found a single point mutation in an infection-sensing gene that causes the autoimmune disorder.
Thanks to genetic clues, scientists discovered that an old stroke therapy that had abandoned for decades might just work.
A new wave of preventative cancer vaccines are set to begin trials.
The same technology behind the COVID-19 vaccines may enable the first damage-reversing heart attack cure.
Israel looks to deploy its “Iron Beam” air-defense system within the year.
Shoving platelet-rich plasma up your nose might restore your sense of smell after COVID. But whether it actually works still needs to be sniffed out.
"Dead" satellites aren't just space junk. They are also targets for hackers to hijack and use to broadcast misinformation.
Using cellulose from trees and a synthetic polymer, MIT researchers have created a material that "is stronger and tougher than some types of bone, and harder than typical aluminum alloys."
In the shadow of the Shard, the mosaics help paint a picture of Roman London.
A small, Seattle-based study will look to see if the psychedelic can alleviate the pandemic’s mental health impact.
One patient’s surprising results have experts cautiously optimistic.
The two-year pilot program will be a test of harm reduction strategies.